EUROFINS SCIENT Net Income/Loss 2018-2023 | ERFSF
EUROFINS SCIENT annual/quarterly net income/loss history and growth rate from 2018 to 2023. Net income/loss can be defined as the company's total income or loss before preferred stock dividends, taken from the Income Statement
- EUROFINS SCIENT net income/loss for the quarter ending June 30, 2023 was $0.822B, a 395.58% increase year-over-year.
- EUROFINS SCIENT net income/loss for the twelve months ending June 30, 2023 was $3.562B, a 290.94% increase year-over-year.
- EUROFINS SCIENT annual net income/loss for 2022 was $0.822B, a 34.26% decline from 2021.
- EUROFINS SCIENT annual net income/loss for 2021 was $1.25B, a 57.59% increase from 2020.
- EUROFINS SCIENT annual net income/loss for 2020 was $0.793B, a 160.86% increase from 2019.
| EUROFINS SCIENT Annual Net Income/Loss (Millions of US $) |
|
|---|---|
| 2022 | $822 |
| 2021 | $1,250 |
| 2020 | $793 |
| 2019 | $304 |
| 2018 | $342 |
| 2017 | $283 |
| 2016 | $0 |
| 2015 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.989B | $7.051B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.299B | 15.60 |
| Cencora (COR) | United States | $46.379B | 18.08 |
| ICON (ICLR) | Ireland | $25.848B | 24.40 |
| DiDi Global (DIDIY) | China | $20.706B | 0.00 |
| Avantor (AVTR) | United States | $14.726B | 21.68 |
| CochLear (CHEOY) | Australia | $13.973B | 0.00 |
| Natera (NTRA) | United States | $13.533B | 0.00 |
| Revvity (RVTY) | United States | $13.407B | 23.52 |
| Medpace Holdings (MEDP) | United States | $12.205B | 40.15 |
| Viatris (VTRS) | United States | $12.109B | 3.62 |
| Charles River Laboratories (CRL) | United States | $10.790B | 20.66 |
| Solventum (SOLV) | United States | $9.423B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $7.951B | 0.00 |
| HealthEquity (HQY) | United States | $7.177B | 46.08 |
| Doximity (DOCS) | United States | $5.537B | 38.78 |
| Bausch + Lomb (BLCO) | Canada | $5.309B | 21.25 |
| Organon (OGN) | United States | $5.246B | 4.98 |
| PACS (PACS) | United States | $4.392B | 0.00 |
| Life Times (LTH) | United States | $3.563B | 37.33 |
| Sotera Health (SHC) | United States | $3.281B | 16.10 |
| GoodRx Holdings (GDRX) | United States | $3.193B | 121.57 |
| Surgery Partners (SGRY) | United States | $3.177B | 29.07 |
| Agilon Health (AGL) | United States | $2.838B | 0.00 |
| Progyny (PGNY) | United States | $2.569B | 44.23 |
| NovoCure (NVCR) | Jersey | $2.296B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.102B | 8.33 |
| Premier (PINC) | United States | $1.927B | 8.24 |
| BrightSpring Health Services (BTSG) | United States | $1.794B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.696B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.591B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.224B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $0.752B | 0.00 |
| CareDx (CDNA) | United States | $0.739B | 0.00 |
| Embecta (EMBC) | United States | $0.738B | 5.02 |
| InnovAge Holding (INNV) | United States | $0.691B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.609B | 6.46 |
| Auna S.A (AUNA) | Luxembourg | $0.600B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 15.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.455B | 0.00 |
| Enhabit (EHAB) | United States | $0.441B | 44.00 |
| ModivCare (MODV) | United States | $0.375B | 7.02 |
| Sonida Senior Living (SNDA) | United States | $0.369B | 0.00 |
| LifeMD (LFMD) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.294B | 16.06 |
| Sharecare (SHCR) | United States | $0.292B | 0.00 |
| MultiPlan (MPLN) | United States | $0.281B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| Beauty Health (SKIN) | United States | $0.244B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.196B | 0.00 |
| Biodesix (BDSX) | United States | $0.184B | 0.00 |
| So-Young (SY) | China | $0.114B | 55.25 |
| Pono Capital Two (PTWO) | United States | $0.072B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.044B | 5.99 |
| IceCure Medical (ICCM) | Israel | $0.037B | 0.00 |
| Oncology Institute (TOI) | United States | $0.034B | 0.00 |
| Nutex Health (NUTX) | United States | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.024B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| KindlyMD (KDLY) | $0.016B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| DermTech (DMTK) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.011B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |